Vermillion Shares Outstanding 2006-2019 | VRML

Vermillion shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Vermillion Annual Shares Outstanding
(Millions of Shares)
2018 70
2017 57
2016 52
2015 47
2014 36
2013 21
2012 15
2011 14
2010 10
2009 7
2008 6
2007
2006
2005
Vermillion Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 97
Q2 2019 76
Q1 2019 76
Q4 2018 70
Q3 2018 75
Q2 2018 69
Q1 2018 60
Q4 2017 57
Q3 2017 57
Q2 2017 56
Q1 2017 54
Q4 2016 52
Q3 2016 52
Q2 2016 52
Q1 2016 52
Q4 2015 47
Q3 2015 50
Q2 2015 43
Q1 2015 43
Q4 2014 36
Q3 2014 36
Q2 2014 36
Q1 2014 36
Q4 2013 21
Q3 2013 23
Q2 2013 20
Q1 2013 15
Q4 2012 15
Q3 2012 15
Q2 2012 15
Q1 2012 15
Q4 2011 14
Q3 2011 15
Q2 2011 15
Q1 2011 13
Q4 2010 11
Q3 2010 10
Q2 2010 10
Q1 2010 10
Q4 2009 7
Q3 2009 6
Q2 2009 6
Q1 2009 6
Q4 2008
Q3 2008
Q2 2008
Q1 2008
Q4 2007
Q3 2007
Q2 2007
Q1 2007
Q4 2006
Q3 2006
Q2 2006
Q1 2006
Q4 2005
Q3 2005
Q2 2005
Q1 2005
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.071B $0.003B
Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. Vermillion also intends to address clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others. Its lead product includes the OVA1 ovarian tumor triage test, which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. In addition to the OVA1 Test, Vermillion has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease. Vermillion, Inc. is based in Fremont, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $122.872B 25.45
Intuitive Surgical (ISRG) United States $66.778B 52.48
Edwards Lifesciences (EW) United States $50.799B 46.13
IDEXX Laboratories (IDXX) United States $22.698B 54.90
Fresenius Medical Care AG KGaA (FMS) Germany $22.488B 15.22
Olympus (OCPNY) Japan $21.073B 158.26
DexCom (DXCM) United States $19.915B 178.34
Teleflex (TFX) United States $16.381B 33.26
Sysmex ADR (SSMXY) Japan $14.885B 40.07
SONOVA HOLDING (SONVY) Switzerland $14.154B 0.00
STERIS (STE) Ireland $12.878B 28.44
Hologic (HOLX) United States $12.603B 19.32
Varian Medical Systems (VAR) United States $11.699B 27.69
ABIOMED (ABMD) United States $8.324B 45.29
Masimo (MASI) United States $8.172B 48.80
Penumbra (PEN) United States $5.892B 191.78
SARTORIUS AG (SARTF) Germany $5.614B 49.28
Globus Medical (GMED) United States $5.547B 34.23
Integra LifeSciences Holdings (IART) United States $5.059B 21.74
Elekta AB (EKTAY) Sweden $4.779B 36.79
Tandem Diabetes Care (TNDM) United States $3.944B 0.00
LivaNova (LIVN) United Kingdom $3.834B 27.60
Wright Medical Group (WMGI) Netherlands $3.755B 227.62
Nevro (NVRO) United States $3.248B 0.00
Cantel Medical (CMD) United States $3.080B 30.53
Integer Holdings (ITGR) United States $2.420B 16.57
Nihon Kohden (NHNKY) Japan $2.365B 23.79
Glaukos (GKOS) United States $2.281B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.584B 31.18
Inogen (INGN) United States $1.566B 49.43
Veracyte (VCYT) United States $1.268B 0.00
Silk Road Medical (SILK) United States $1.119B 0.00
Tactile Systems Technology (TCMD) United States $1.104B 126.15
Natus Medical (NTUS) United States $1.096B 26.35
OPKO Health (OPK) United States $1.018B 0.00
Mesa Laboratories (MLAB) United States $1.011B 37.48
CryoLife (CRY) United States $0.923B 94.61
Accelerate Diagnostics (AXDX) United States $0.908B 0.00
Luminex (LMNX) United States $0.892B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.854B 28.37
Pacific Biosciences Of California (PACB) United States $0.717B 0.00
Intersect ENT (XENT) United States $0.673B 0.00
AxoGen (AXGN) United States $0.615B 0.00
OrthoPediatrics (KIDS) United States $0.582B 0.00
AngioDynamics (ANGO) United States $0.572B 20.55
Quotient (QTNT) Switzerland $0.553B 0.00
Alphatec Holdings (ATEC) United States $0.447B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.441B 13.33
Si-Bone (SIBN) United States $0.437B 0.00
Sientra (SIEN) United States $0.394B 0.00
GenMark Diagnostics (GNMK) United States $0.326B 0.00
Semler Scientific (SMLR) United States $0.290B 39.09
ViewRay (VRAY) United States $0.288B 0.00
IRadimed (IRMD) United States $0.269B 37.74
Stereotaxis (STXS) United States $0.250B 0.00
SeaSpine Holdings (SPNE) United States $0.247B 0.00
Accuray (ARAY) United States $0.245B 0.00
CRH Medical (CRHM) Canada $0.208B 58.00
Fluidigm (FLDM) United States $0.161B 0.00
RTI Surgical (RTIX) United States $0.145B 39.20
EDAP TMS S.A (EDAP) France $0.141B 37.38
ConforMIS (CFMS) United States $0.124B 0.00
Second Sight Medical Products (EYES) United States $0.104B 0.00
Spectral Diagnostics (EDTXF) Canada $0.097B 0.00
Electromed (ELMD) United States $0.084B 30.21
T2 Biosystems (TTOO) United States $0.084B 0.00
Neuronetics (STIM) United States $0.077B 0.00
TransEnterix (TRXC) United States $0.064B 0.00
Apollo Endosurgery (APEN) United States $0.061B 0.00
Sensus Healthcare (SRTS) United States $0.059B 0.00
Bioanalytical Systems (BASI) United States $0.042B 0.00
Ekso Bionics Holdings (EKSO) United States $0.040B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.040B 0.00
Xtant Medical Holdings (XTNT) United States $0.024B 0.00
Neovasc (NVCN) Canada $0.021B 0.00
Ra Medical Systems (RMED) United States $0.019B 0.00
Helius Medical Technologies (HSDT) United States $0.019B 0.00
ReWalk Robotics (RWLK) Israel $0.015B 0.00
American Shared Hospital Services (AMS) United States $0.014B 20.13
OBALON THERPTCS (OBLN) United States $0.014B 0.00
Avinger (AVGR) United States $0.013B 0.00
Nanovibronix (NAOV) United States $0.013B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.013B 0.00
Lianluo Smart (LLIT) China $0.009B 0.00
DarioHealth (DRIO) Israel $0.009B 0.00
Restoration Robotics (VERO) Canada $0.009B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Dynatronics (DYNT) United States $0.006B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
Viveve Medical (VIVE) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Allied Healthcare Products (AHPI) United States $0.004B 0.00
Nuvectra (NVTR) United States $0.004B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
InspireMD (NSPR) Israel $0.001B 0.00